Healthy volunteers help test new tablet form of experimental drug
NCT ID NCT06342700
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 23 times
Summary
This study tested two different tablet forms of the experimental drug rilzabrutinib in 28 healthy adults aged 18 to 55. The goal was to see how well each form is absorbed by the body, both with and without food. Participants took a single dose of each tablet in a random order, with short breaks in between. This research helps determine the best tablet form for future studies, but does not provide any treatment for a disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nucleus Network Site Number : 8400001
Saint Paul, Minnesota, 55114, United States
Conditions
Explore the condition pages connected to this study.